A team of Japanese researchers is developing a medication that enables tooth regrowth. The innovative drug will target individuals lacking a complete set of adult teeth due to congenital factors such as anodontia. Clinical trials are set to begin in 2024, with the aim of making the drug available by 2030. The breakthrough could impact dental treatments such as dentures or implants.
LockBit ransomware group falls victim to hackers itself
A data leak has disclosed information about negotiations with victims, Bitcoin wallet addresses, affiliate accounts, and details of attacks.
